About Centene (NYSE:CNC)
Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company's Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children's Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace. Its Specialty Services segment consists of its specialty companies offering a range of healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations, as well as to its own subsidiaries.
Industry, Sector and Symbol
Industry Managed Health Care
Sub-IndustryManaged Health Care
Trailing P/E Ratio21.3688699360341
Forward P/E Ratio13.92
Sales & Book Value
Annual Sales$48.38 billion
Price / Sales0.36
Cash Flow$7.24 per share
Price / Cash13.84
Book Value$39.58 per share
Price / Book2.53
Net Income$828 million
Return on Equity13.68%
Return on Assets4.08%
Centene (NYSE:CNC) Frequently Asked Questions
What is Centene's stock symbol?
Centene trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNC."
How were Centene's earnings last quarter?
Centene Corporation (NYSE:CNC) released its quarterly earnings data on Tuesday, February, 6th. The company reported $0.97 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.94 by $0.03. The business earned $12.81 billion during the quarter, compared to analysts' expectations of $12.25 billion. Centene had a return on equity of 13.68% and a net margin of 1.71%. The business's quarterly revenue was up 7.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.19 EPS. View Centene's Earnings History.
When will Centene make its next earnings announcement?
What guidance has Centene issued on next quarter's earnings?
Centene issued an update on its FY18 earnings guidance on Tuesday, February, 6th. The company provided EPS guidance of $6.95-7.35 for the period, compared to the Thomson Reuters consensus estimate of $5.76. The company issued revenue guidance of $60.6-61.4 billion, compared to the consensus revenue estimate of $60.19 billion.
Where is Centene's stock going? Where will Centene's stock price be in 2018?
17 brokerages have issued 1 year price objectives for Centene's shares. Their forecasts range from $75.00 to $135.00. On average, they anticipate Centene's stock price to reach $110.81 in the next twelve months. View Analyst Ratings for Centene.
What are Wall Street analysts saying about Centene stock?
Here are some recent quotes from research analysts about Centene stock:
- 1. According to Zacks Investment Research, "Year to date, Centene’s shares have outperformed the industry. The company’s strong and consistent performance is likely to have generated confidence among the investors. It has seen substantial inorganic growth in the last five years. The acquisition of Health Net in 2016 bolstered the company’s growth, expansion and asset base. Its solid financial position provides a major boost to its capital deployment initiatives. The company’s strong Managed care segment also contributes to its strong results. The guidance raise for 2017 and strong earnings outlook for 2018 instills shareholders' confidence in the company. However, rising level of debt hurts the company's profitability. Moreover, increasing costs also continue to weigh on the margins." (12/26/2017)
- 2. Cantor Fitzgerald analysts commented, "Individual market outlook remains solid. CNC indicates that individual exchange membership (for 2018 coverage year) has been in line with its expectations. CNC is the only company in our managed care coverage universe to materially benefit from exchanges. We attribute the success to the strategy to target certain demographics in existing Medicaid markets. The company believes (and we agree) that the potential repeal of the mandate should not have an impact on membership as most of its members are highly subsidized." (12/18/2017)
Who are some of Centene's key competitors?
Some companies that are related to Centene include Fresenius Medical Care AG & Co. (FMS), Illumina (ILMN), Shire (SHP), Edwards Lifesciences (EW), Essilor International (EI), C R Bard (BCR), Teva Pharmaceutical Industries (TEVA), Cerner (CERN), Align Technology (ALGN), Incyte (INCY), IDEXX Laboratories (IDXX), Hospira (HSP), BioMarin Pharmaceutical (BMRN), Quest Diagnostics (DGX), Medivation (MDVN), Ramsay Health Care (RHC), DENTSPLY SIRONA (XRAY) and Nektar Therapeutics (NKTR).
Who are Centene's key executives?
Centene's management team includes the folowing people:
- Michael F. Neidorff, Chairman of the Board, Chief Executive Officer (Age 74)
- Cynthia J. Brinkley, President, Chief Operating Officer (Age 57)
- Jeffrey A. Schwaneke CPA, Chief Financial Officer, Executive Vice President, Treasurer (Age 41)
- Mark J. Brooks, Executive Vice President, Chief Information Officer (Age 47)
- Keith H. Williamson, Executive Vice President, General Counsel, Secretary (Age 64)
- Christopher D. Bowers, Executive Vice President - Marketing (Age 61)
- Jesse N. Hunter, Executive Vice President of Mergers & Acquisitions and Chief Strategy Officer (Age 41)
- Christopher R. Isaak, Senior Vice President, Corporate Controller and Chief Accounting Officer (Age 50)
- Kevin J. Counihan, Senior Vice President of Products
- Christopher A. Koster, Senior Vice President - Corporate Services
Who owns Centene stock?
Centene's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.04%), Wells Fargo & Company MN (2.07%), Geode Capital Management LLC (1.30%), Deutsche Bank AG (1.02%), TIAA CREF Investment Management LLC (0.84%) and Amundi Pioneer Asset Management Inc. (0.80%). Company insiders that own Centene stock include Carol Goldman, Christopher D Bowers, Jeffrey A Schwaneke, Jesse N Hunter, Keith H Williamson, Kenneth Rone Baldwin, Mark J Brooks, Michael F Neidorff, Richard A Gephardt, Robert K Ditmore and Stephen Wallace. View Institutional Ownership Trends for Centene.
Who sold Centene stock? Who is selling Centene stock?
Centene's stock was sold by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Earnest Partners LLC, TIAA CREF Investment Management LLC, Victory Capital Management Inc., Wells Fargo & Company MN, Bank of New York Mellon Corp, Teacher Retirement System of Texas and Teachers Advisors LLC. Company insiders that have sold Centene company stock in the last year include Christopher D Bowers, Jeffrey A Schwaneke, Jesse N Hunter, Keith H Williamson, Mark J Brooks, Michael F Neidorff, Richard A Gephardt and Robert K Ditmore. View Insider Buying and Selling for Centene.
Who bought Centene stock? Who is buying Centene stock?
Centene's stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Acadian Asset Management LLC, AGF Investments Inc., Arrowstreet Capital Limited Partnership, Element Capital Management LLC, Allianz Asset Management GmbH, Carillon Tower Advisers Inc. and Deutsche Bank AG. Company insiders that have bought Centene stock in the last two years include Robert K Ditmore and Stephen Wallace. View Insider Buying and Selling for Centene.
How do I buy Centene stock?
Shares of Centene can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Centene's stock price today?
One share of Centene stock can currently be purchased for approximately $100.22.
How big of a company is Centene?
Centene has a market capitalization of $17.29 billion and generates $48.38 billion in revenue each year. The company earns $828 million in net income (profit) each year or $4.69 on an earnings per share basis. Centene employs 30,500 workers across the globe.
How can I contact Centene?
Centene's mailing address is 7700 Forsyth Blvd, ST. LOUIS, MO 63105-1807, United States. The company can be reached via phone at +1-314-7254477 or via email at [email protected]
MarketBeat Community Rating for Centene (CNC)MarketBeat's community ratings are surveys of what our community members think about Centene and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Centene (NYSE:CNC) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Buy||Buy||Buy||Buy|
|Consensus Rating Score: ||2.82||2.72||2.67||2.67|
|Ratings Breakdown: ||0 Sell Rating(s)|
3 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
|1 Sell Rating(s)|
3 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
|1 Sell Rating(s)|
4 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
|1 Sell Rating(s)|
4 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$110.81||$104.00||$98.88||$85.60|
|Price Target Upside: ||7.49% upside||1.37% upside||6.43% upside||5.46% upside|
Centene (NYSE:CNC) Consensus Price Target History
Centene (NYSE:CNC) Analyst Ratings History
(Data available from 2/18/2016 forward)
Centene (NYSE:CNC) Earnings History and Estimates Chart
Centene (NYSE CNC) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/6/2018||Q4 2017||$0.94||$0.97||$12.25 billion||$12.81 billion||View||Listen|
|10/24/2017||Q3 2017||$1.24||$1.35||$11.75 billion||$11.90 billion||View||N/A|
|7/25/2017||Q2 2017||$1.30||$1.59||$11.69 billion||$11.95 billion||View||N/A|
|4/25/2017||Q1 17||$1.06||$1.12||$11.44 billion||$11.72 billion||View||N/A|
|2/7/2017||Q416||$1.11||$1.19||$10.94 billion||$11.91 billion||View||N/A|
|10/25/2016||Q316||$1.15||$1.11||$10.96 million||$10.85 billion||View||Listen|
|7/26/2016||Q216||$1.09||$1.29||$10.80 billion||$10.90 billion||View||Listen|
|4/26/2016||Q116||$0.74||$0.74||$7.88 billion||$6.95 billion||View||Listen|
|2/9/2016||Q415||$0.82||$0.95||$6.14 billion||$6.30 billion||View||N/A|
|10/27/2015||Q315||$0.78||$0.84||$5.79 billion||$5.82 billion||View||Listen|
|7/28/2015||Q215||$0.69||$0.73||$5.54 billion||$5.51 billion||View||Listen|
|4/28/2015||Q115||$0.48||$0.52||$5.12 billion||$5.13 billion||View||Listen|
|2/3/2015||Q414||$1.70||$1.74||$4.62 billion||$4.42 billion||View||Listen|
|10/28/2014||Q314||$0.96||$1.22||$4.23 billion||$4.35 billion||View||Listen|
|7/22/2014||Q214||$0.73||$0.79||$3.66 billion||$4.02 billion||View||Listen|
|4/22/2014||Q1||$0.44||$0.57||$3.25 billion||$3.35 billion||View||Listen|
|2/4/2014||Q413||$0.83||$0.84||$2.93 billion||$2.86 billion||View||Listen|
|10/22/2013||Q313||$0.84||$0.87||$2.68 billion||$2.70 billion||View||Listen|
|7/23/2013||Q2 2013||$0.62||$0.77||$2.63 billion||$2.73 billion||View||Listen|
|4/23/2013||Q1 2013||$0.38||$0.42||$2.46 billion||$2.54 billion||View||Listen|
|2/5/2013||Q4 2012||$0.32||$0.17||$2.40 billion||$2.30 billion||View||Listen|
Centene (NYSE:CNC) Earnings Estimates
2018 EPS Consensus Estimate: $7.16
2019 EPS Consensus Estimate: $8.21
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Centene (NYSE:CNC)
No dividend announcements for this company have been tracked by MarketBeat.com
Centene (NYSE CNC) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 3.00%
Institutional Ownership Percentage: 92.03%
Centene (NYSE CNC) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|2/8/2018||Robert K. Ditmore||Director||Sell||8,750||$104.13||$911,137.50|| |
|1/8/2018||Robert K. Ditmore||Director||Sell||8,750||$104.30||$912,625.00|| |
|1/2/2018||Keith H. Williamson||EVP||Sell||5,000||$100.11||$500,550.00|| |
|12/19/2017||Jesse N. Hunter||EVP||Sell||10,000||$98.73||$987,300.00|| |
|10/26/2017||Robert K. Ditmore||Director||Sell||4,167||$90.42||$376,780.14|| |
|8/1/2017||Christopher D. Bowers||EVP||Sell||4,000||$79.43||$317,720.00|| |
|7/27/2017||Robert K. Ditmore||Director||Sell||4,167||$82.59||$344,152.53|| |
|7/6/2017||Michael F. Neidorff||Chairman||Sell||35,000||$80.26||$2,809,100.00|| |
|6/12/2017||Richard A. Gephardt||Director||Sell||4,350||$77.38||$336,603.00|| |
|6/2/2017||Mark J. Brooks||SVP||Sell||2,161||$75.43||$163,004.23|| |
|6/2/2017||Robert K. Ditmore||Director||Sell||3,900||$75.43||$294,177.00|| |
|5/1/2017||Jesse N. Hunter||EVP||Sell||5,000||$74.40||$372,000.00|| |
|4/27/2017||Christopher D. Bowers||EVP||Sell||3,150||$72.80||$229,320.00|| |
|4/27/2017||Robert K. Ditmore||Director||Sell||4,167||$72.43||$301,815.81|| |
|3/27/2017||Keith H. Williamson||EVP||Sell||6,000||$70.03||$420,180.00|| |
|3/13/2017||Jeffrey A. Schwaneke||CFO||Sell||2,000||$68.52||$137,040.00|| |
|2/13/2017||Jesse N. Hunter||EVP||Sell||5,000||$69.54||$347,700.00|| |
|12/1/2016||Mark J. Brooks||SVP||Sell||1,099||$58.00||$63,742.00|| |
|11/7/2016||Jesse N. Hunter||EVP||Sell||5,000||$65.00||$325,000.00|| |
|10/3/2016||Carol Goldman||VP||Sell||10,000||$66.36||$663,600.00|| |
|10/3/2016||Kenneth Rone Baldwin||EVP||Sell||6,000||$66.58||$399,480.00|| |
|9/7/2016||Robert K. Ditmore||Director||Buy||150||$67.00||$10,050.00|| |
|7/1/2016||Kenneth Rone Baldwin||EVP||Sell||6,000||$71.00||$426,000.00|| |
|6/29/2016||Richard A. Gephardt||Director||Sell||15,910||$68.89||$1,096,039.90|| |
|6/24/2016||Keith H. Williamson||EVP||Sell||4,000||$70.00||$280,000.00|| |
|6/6/2016||Mark J Brooks||SVP||Sell||3,914||$65.01||$254,449.14||30,605|| |
|4/28/2016||Jesse N Hunter||EVP||Sell||10,000||$65.17||$651,700.00||216,329|| |
|4/1/2016||Kenneth Rone Baldwin||EVP||Sell||6,000||$60.87||$365,220.00||123,494|| |
|3/23/2016||Carol Goldman||VP||Sell||15,000||$62.96||$944,400.00||78,500|| |
|1/4/2016||Kenneth Rone Baldwin||EVP||Sell||6,000||$64.68||$388,080.00||131,770|| |
|12/22/2015||Carol Goldman||VP||Sell||25,000||$65.19||$1,629,750.00||97,448|| |
|12/22/2015||Jeffrey A Schwaneke||CAO||Sell||2,000||$65.09||$130,180.00||82,574|| |
|10/29/2015||Carol Goldman||VP||Sell||5,000||$60.88||$304,400.00||103,614|| |
|7/1/2015||Carol Goldman||VP||Sell||5,000||$81.20||$406,000.00|| |
|6/22/2015||Keith H Williamson||EVP||Sell||7,000||$80.87||$566,090.00|| |
|6/18/2015||William N Scheffel||CFO||Sell||25,290||$79.14||$2,001,450.60|| |
|5/4/2015||Donald G Imholz||EVP||Sell||5,000||$65.08||$325,400.00|| |
|4/30/2015||Carol Goldman||VP||Sell||15,998||$63.48||$1,015,553.04|| |
|4/30/2015||Donald G Imholz||EVP||Sell||5,000||$63.72||$318,600.00|| |
|4/30/2015||Robert K Ditmore||Director||Sell||15,000||$63.83||$957,450.00|| |
|4/6/2015||Michael F Neidorff||CEO||Sell||10,000||$70.43||$704,300.00|| |
|4/1/2015||Jesse N Hunter||EVP||Sell||5,000||$69.66||$348,300.00|| |
|3/19/2015||Keith H Williamson||EVP||Sell||5,000||$70.18||$350,900.00|| |
|3/13/2015||Tommy G Thompson||Director||Sell||16,000||$65.36||$1,045,760.00|| |
|3/9/2015||Robert K Ditmore||Director||Sell||15,000||$63.19||$947,850.00|| |
|1/2/2015||Carol Goldman||VP||Sell||8,400||$104.87||$880,908.00|| |
|1/2/2015||Jesse N Hunter||EVP||Sell||2,500||$104.87||$262,175.00|| |
|12/16/2014||Jeffrey A Schwaneke||CAO||Sell||5,000||$101.80||$509,000.00|| |
|10/1/2014||Jesse N Hunter||EVP||Sell||2,500||$81.42||$203,550.00|| |
|9/22/2014||Carol Goldman||VP||Sell||12,500||$81.85||$1,023,125.00|| |
|9/18/2014||Donald G Imholz||EVP||Sell||5,000||$80.10||$400,500.00|| |
|9/15/2014||Keith H Williamson||EVP||Sell||4,000||$77.48||$309,920.00|| |
|9/9/2014||Jeffrey A Schwaneke||CAO||Sell||1,000||$79.51||$79,510.00|| |
|9/9/2014||Jesse N Hunter||EVP||Sell||5,000||$79.35||$396,750.00|| |
|9/2/2014||Donald G Imholz||EVP||Sell||5,000||$77.32||$386,600.00|| |
|8/28/2014||Jeffrey A Schwaneke||CAO||Sell||1,000||$77.02||$77,020.00|| |
|5/12/2014||Jason Harrold||EVP||Sell||2,500||$70.00||$175,000.00||45,048|| |
|4/2/2014||Jason Harrold||EVP||Sell||5,000||$62.19||$310,950.00||48,382|| |
|3/31/2014||Edmund Kroll||SVP||Sell||5,000||$62.00||$310,000.00||41,780|| |
|3/31/2014||William Scheffel||CFO||Sell||17,895||$61.99||$1,109,311.05||85,528|| |
|2/6/2014||Jesse Hunter||EVP||Sell||5,000||$61.66||$308,300.00||97,650|| |
|2/6/2014||Michael Neidorff||CEO||Sell||10,000||$62.00||$620,000.00||1,745,926|| |
|12/17/2013||Orlando Ayala||Director||Buy||17,600||$56.41||$992,816.00||29,193|| |
|7/25/2013||Jeffrey A Schwaneke||CAO||Sell||3,000||$57.40||$172,200.00|| |
|7/25/2013||Jesse N Hunter||EVP||Sell||5,000||$57.41||$287,050.00|| |
|6/13/2013||Keith H Williamson||EVP||Sell||5,800||$50.25||$291,450.00|| |
|6/7/2013||Donald G Imholz||EVP||Sell||5,000||$50.00||$250,000.00|| |
|6/3/2013||Carol Goldman||VP||Sell||10,000||$49.28||$492,800.00|| |
|6/3/2013||Jesse N Hunter||EVP||Sell||6,000||$48.28||$289,680.00|| |
|5/30/2013||Jason M Harrold||EVP||Sell||5,000||$50.80||$254,000.00|| |
|5/30/2013||Jeffrey A Schwaneke||CAO||Sell||3,000||$50.68||$152,040.00|| |
|5/30/2013||William N Scheffel||CFO||Sell||22,191||$50.80||$1,127,302.80|| |
|5/10/2013||Keith H Williamson||EVP||Sell||3,000||$50.00||$150,000.00|| |
|12/4/2012||Carol Goldman||VP||Sell||15,000||$45.15||$677,250.00|| |
|12/4/2012||Keith H Williamson||EVP||Sell||9,000||$45.10||$405,900.00|| |
Centene (NYSE CNC) News Headlines
Centene (NYSE:CNC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Centene (NYSE:CNC) Income Statement, Balance Sheet and Cash Flow Statement
Centene (NYSE CNC) Stock Chart for Sunday, February, 18, 2018